The largest database of trusted experimental protocols

31 protocols using mouse serum

1

Stability Assessment of MCL Analogs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess the stability of MCL analogs, free compounds (5 μg) were added to PBS (pH 7.4), 100% mouse serum (Life Technologies, Cat #: 10 401), or 1:1 [100% mouse serum]/[PBS] in room temperature. Additionally, drug-loaded NPs in ddH2O was added to mouse serum (1:1/[100% serum]). Samples were extracted twice with ethyl acetate (300 μL) by centrifugation at 11 000 rpm for 2 mins. Combined supernatants were dried under a nitrogen stream, dissolved in methanol (200 μL), filtered using 0.22 μm PTFE filters, and then analyzed via HPLC as described previously.
+ Open protocol
+ Expand
2

Stability Profiling of Drug Candidates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Compounds 1-4 were incubated at 37 °C in a shaking incubator as PBS solutions (pH 7.4; 100 μg/ml). Aliquots (200 μl) were collected at subsequent time points (0, 15 min, 1 h, 3 h, 6 h, 24 h, 96 h) and frozen at -20 °C. The samples were analyzed in triplicate by LC-MS. Peaks relative to the pro-drugs were integrated and area values from samples at different time points were used to obtain fractions of intact test compounds. Fraction values were plotted to obtain stability profiles showed in figure 2.
Analogously, test compounds were dissolved in DMSO (10 μl), diluted with freshly thawed mouse serum (Invitrogen) (100 μg/ml) and incubated at 37 °C in a shaking incubator. Aliquots (100 µl) were collected at subsequent time points (0, 20 min, 1 h, 3 h, 6 h, 24 h and 48 h) and frozen at -20°C. Samples were thawed and diluted with four volumes of MeOH (400 μl). After vigorous vortex agitation for 1 min, the protein precipitate was spun down and 400 μl of the supernatant was lyophilized overnight. The resulting solid material was re-dissolved in 200 µl of water, filtered and analyzed as described above.
+ Open protocol
+ Expand
3

Multiparametric Immune Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs, monocytes, MDMs, and LPMCs were stained in PBS with 1% FCS and 0.1% sodium azide (FACS buffer) by first preincubating in 2% mouse serum (Invitrogen), followed by staining for 20 min on ice (see Table S1 for details of all antibodies used). Cells were analyzed using a LSR Fortessa cytometer (BD Biosciences). Data were analyzed using Flowjo v10.1 (TreeStar).
+ Open protocol
+ Expand
4

In Vitro Stability Evaluation of ADCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
ADCs were incubated at a concentration of 150 μg/mL in mouse serum (Invitrogen) at 37 °C in a shaking incubator. At various time points, aliquots were purified by affinity chromatography onto an antigen-coated resin, based on 11-EDA-12 coupled to CNBr-activated Sepharose (GE Healthcare), washed with PBS and then eluted with 0.1 M glycine solution (pH = 3), prior to analysis by SDS-PAGE and mass spectrometry. In the case of SIP(F8)-SS-DM1, the relative concentration of ADC was assessed by ESI-MS using SIP(F8) coupled to iodoacetamide as internal standard. For IgG(F8)-SS-DM1, the relative ratios of mass spectrometry peak intensity for the unmodified and the drug-modified light chain were used for the quantification of drug release rates [Figure 4].
+ Open protocol
+ Expand
5

Activated PBMC cytokine profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Banked frozen responder PBMCs were thawed and rested overnight. Responder PBMCs were stimulated with donor cell lysate at 1:5 ratio for 6 hours in the presence of Golgi-plug (BD) and Monensin (eBioscience) at 37 °C, 5% CO2. Cells were then washed, and surface stained with anti-CD3 (Biolegend, San Diego, CA), -CD8, -CXCR5, (BD) for 20 minutes at 4 οC, washed, and fixed with 1% paraformaldehyde (Sigma, St. Louis, MO) for 40 minutes. Subsequently, the cells were permeabilized and incubated with mouse serum (Invitrogen, Frederick, MD) for 5 minutes at room temperature, followed by anti-CD40L (eBioscience) and IL-21 monclonal Abs (BD) for 30 minutes at room temperature. Cell were washed and immediately acquired as described previously.
+ Open protocol
+ Expand
6

Serum-mediated Decay of mLiTCo Binding

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified mLiTCo and mLiTCo-Albu were incubated in mouse serum (Invitrogen) at 37°C, for at least 7 days. The binding activity of the sample at 0 h was set as 100% in order to calculate the time corresponding to percentage of decay in binding activity. Samples were analyzed with Thermo Scientific Multiskan FC photometer and GraphPad Prism 8.4.0 software.
+ Open protocol
+ Expand
7

Allogeneic Blood WBC Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
DCreg were spiked into a set volume of allogeneic whole blood from a healthy control equivalent to 1:10 ratio to white blood cells (WBC) and incubated for 18 h at 37C and 5% CO2. Red blood cells (RBC) were then lysed using ACK lysis buffer (Gibco) and the WBC blocked with mouse serum (Invitrogen) and stained with mAb, including HLA, as described for flow cytometry (FC) analysis.
+ Open protocol
+ Expand
8

Monocyte MR Expression in Alcoholic Hepatitis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To investigate whether peripheral monocytes express MR and therefore could be a source of sMR, we studied the MR expression using flow cytometry. 20 patients with AH, 10 patients with AC, and 10 HCs was studied. Peripheral blood mononuclear cells were isolated by Ficoll-Hypaque (GE Healthcare Bio-sciences, Uppsala, Sweden) from EDTA whole blood samples. Samples were stored at -140°C until en bloc analyses. Cells were thawed in PBS containing 20% heat-inactivated pooled human AB-serum and blocked with 10 μl heat-inactivated mouse serum (Invitrogen, Carlsbad, California, USA) before staining with optimized amounts of fluorescent-conjugated antibodies; CD14-APC (clone MFP9; BD Bioscience, San Diego, CA), CD206-FITC (clone 19.2; BD Bioscience, San Diego, CA). Relevant isotype controls were included. The samples were analysed within 24 hours of preparation using a FACSCanto instrument (BD Bioscience). Data analyses were carried out using FlowJo v10.1 (Tree Star Inc., Ashland, OR). We report the relative fluorescent intensity (MFI) of sMR on the CD14+ monocytes.
+ Open protocol
+ Expand
9

ELISA-based IFN-γ quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma collected from blood samples with or without S1 peptide stimulation was assessed for interferon-γ (IFN-γ) content by ELISA (DY285B, R&D systems) according to the manufacturer’s instructions. To minimize non-specific reactivity, plasma was diluted (1:2) in PBS containing 1% BSA and 10% mouse serum (Invitrogen). Plates were analysed for optical densities at 450 nm and 570 nm using a FLUOstar Omega plate reader (BMG, Ortenberg, Germany). Levels of IFN-γ induced in response to S1 peptides, with background IFN-γ production in unstimulated samples subtracted, are presented throughout the manuscript. The limit of detection (LOD) of the assay was 10 pg/ml as reported elsewhere,13 (link) and thus this threshold was used in the study.
+ Open protocol
+ Expand
10

CTC Detection to Evaluate Anti-miR-31 Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
The described animal protocols were reviewed and approved by Dartmouth's Institutional Animal Care and Use Committee (IACUC). To compare the number of CTC in mouse blood from wild-type FVB mice and transgenic CEO mice that develop spontaneous lung tumors, six to seven mice of each arm were used. The following study was then performed to compare the number of CTC in mouse blood in correlation to lung pathology using anti-miR-31 LNA as a novel therapeutic strategy. Seven- month old, sex-matched CEO mice were each injected with either vehicle (PBS with 10% mouse serum (Invitrogen, Carlsbad, CA)), control LNA (3 mg/ml), or anti-miR-31 LNA (3 mg/ml) via tail veins once daily for 5 days before being euthanized using an IACUC-approved protocol at 24 hrs after the last treatment. Note that three mice treated with vehicle were 17 months old. Five to six mice of each treatment group were used. Blood for CTC detection was drawn via cardiac puncture and lung tissues were harvested, formalin-fixed and paraffin-embedded, processed and sectioned for histopathology and hematoxylin and eosin (H&E) staining. The pathologist was blinded to the treatment administered.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!